Delorean Corporation (ASX:DEL): How Does NSW1 Financial Close Change Its Bioenergy Timeline?

Aditi Sarkar

12 November 2026 10:17 PM AEDT

Delorean Corporation (ASX:DEL): How Does NSW1 Financial Close Change Its Bioenergy Timeline?

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

Delorean Corporation (ASX:DEL) confirmed financial close on its NSW1 project.
The Horsley Park bioenergy Facility carries an AUD 62.1 million project cost.
Government grants totalling AUD 30.5 million form part of the funding structure.
The September report placed SA1 construction progress at approximately 90%.

Delorean Corporation Limited (ASX:DEL) develops, constructs and operates bioenergy infrastructure that converts organic waste into renewable gas, alongside related engineering services. Its stock closed at AUD 0.086 on 12 November 2026. In a November announcement, the company confirmed financial close for its NSW1 Horsley Park facility, allowing procurement to proceed before planned site construction in 2027. Delorean is also progressing its SA1 Salisbury project, with future Operating Revenue dependent on completing commissioning and moving facilities into commercial operation.

Bioenergy Operations and Project Portfolio

Delorean Corporation (ASX:DEL) combines engineering and project development with a model under which it intends to own and operate selected renewable gas infrastructure. The company’s facilities process separated organic waste to produce biomethane, and some projects also involve other renewable-energy or waste-management outputs. NSW1 at Horsley Park in New South Wales and SA1 at Salisbury in South Australia are distinct Assets at different development stages. Delorean also provides contracted engineering, operations and maintenance services, including work associated with an established Victorian bioenergy facility.

NSW1 Funding and Construction Programme

Delorean Corporation (ASX:DEL) announced on 9 November 2026 that financial close had been achieved for the AUD 62.1 million NSW1 development. The stated funding components included an AUD 20 million New South Wales government grant, AUD 10.5 million from the Australian Renewable Energy Agency, a AUD 20 million Westpac facility, previously funded project Capital costs and other funding sources. The company also disclosed private-placement commitments. Financial close activated its 25-year gas Supply and site-lease agreements connected with the project. Procurement was scheduled to start in November, with site construction expected in the first quarter of 2027; these remain future activities.

Production Design, SA1 and Financial Results

NSW1 is designed to process approximately 120,000 tonnes of organic waste annually, with approvals extending to 150,000 tonnes. Delorean Corporation (ASX:DEL) indicated approximately 253,000 gigajoules of renewable gas production per year as a project figure. The gas is intended for direct use in nearby brick Manufacturing and the announced assumptions indicate a reduction in the facility’s natural-gas use. Separately, SA1 was around 90% constructed at the September quarter-end, with commissioning and first gas expected in FY2027. FY2026 accounts recorded revenue of approximately AUD 9.34 million, EBITDA of about AUD 0.98 million and a net loss after tax of approximately AUD 0.12 million. These historical figures do not include a full year of commercial output from the new owned facilities.

Funding, Commissioning and Delivery Risks

Delorean Corporation (ASX:DEL) reported September-quarter customer receipts of approximately AUD 0.8 million and a closing cash balance of AUD 2.5 million, excluding specifically identified subsequent receipts. Project execution still involves procurement, construction costs, commissioning, feedstock availability and compliance with relevant operating approvals. NSW1’s grants and financing arrangements have conditions and project purposes, while commercial revenues will depend on facilities operating as intended. The next relevant disclosures include SA1’s first waste acceptance, renewable gas delivery, NSW1 procurement progress and subsequent financial reporting on the company’s construction and operating activities.

Key Insights

Financial close is a completed funding milestone for NSW1, not the completion of the facility itself. Delorean’s 2026 reporting also documented substantial progress at SA1, while its financial statements reflected a Business still developing owned infrastructure. Upcoming milestones will show how the announced funding, construction programme and commissioning work translate into operating capacity.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.